Index
1 Market Overview of Circadian Rhythm Sleep Disorders
1.1 Circadian Rhythm Sleep Disorders Market Overview
1.1.1 Circadian Rhythm Sleep Disorders Product Scope
1.1.2 Circadian Rhythm Sleep Disorders Market Status and Outlook
1.2 Global Circadian Rhythm Sleep Disorders Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Circadian Rhythm Sleep Disorders Market Size by Region (2018-2029)
1.4 Global Circadian Rhythm Sleep Disorders Historic Market Size by Region (2018-2023)
1.5 Global Circadian Rhythm Sleep Disorders Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Circadian Rhythm Sleep Disorders Market Size (2018-2029)
1.6.1 North America Circadian Rhythm Sleep Disorders Market Size (2018-2029)
1.6.2 Europe Circadian Rhythm Sleep Disorders Market Size (2018-2029)
1.6.3 Asia-Pacific Circadian Rhythm Sleep Disorders Market Size (2018-2029)
1.6.4 Latin America Circadian Rhythm Sleep Disorders Market Size (2018-2029)
1.6.5 Middle East & Africa Circadian Rhythm Sleep Disorders Market Size (2018-2029)
2 Circadian Rhythm Sleep Disorders Market by Type
2.1 Introduction
2.1.1 Delayed Sleep Phase Disorder (DSP)
2.1.2 Jet Lag Disorder
2.1.3 Irregular Sleep-Wake Rhythm
2.1.4 Free-Running (nonentrained) Type
2.1.5 Shift Work Disorder
2.1.6 Advanced Sleep Phase Disorder (ASP)
2.2 Global Circadian Rhythm Sleep Disorders Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Circadian Rhythm Sleep Disorders Historic Market Size by Type (2018-2023)
2.2.2 Global Circadian Rhythm Sleep Disorders Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Circadian Rhythm Sleep Disorders Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Circadian Rhythm Sleep Disorders Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Circadian Rhythm Sleep Disorders Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Circadian Rhythm Sleep Disorders Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Circadian Rhythm Sleep Disorders Revenue Breakdown by Type (2018-2029)
3 Circadian Rhythm Sleep Disorders Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Sleep Centers
3.1.3 Home Care Settings
3.2 Global Circadian Rhythm Sleep Disorders Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Circadian Rhythm Sleep Disorders Historic Market Size by Application (2018-2023)
3.2.2 Global Circadian Rhythm Sleep Disorders Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Circadian Rhythm Sleep Disorders Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Circadian Rhythm Sleep Disorders Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Circadian Rhythm Sleep Disorders Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Circadian Rhythm Sleep Disorders Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Circadian Rhythm Sleep Disorders Revenue Breakdown by Application (2018-2029)
4 Circadian Rhythm Sleep Disorders Competition Analysis by Players
4.1 Global Circadian Rhythm Sleep Disorders Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Circadian Rhythm Sleep Disorders as of 2022)
4.3 Date of Key Players Enter into Circadian Rhythm Sleep Disorders Market
4.4 Global Top Players Circadian Rhythm Sleep Disorders Headquarters and Area Served
4.5 Key Players Circadian Rhythm Sleep Disorders Product Solution and Service
4.6 Competitive Status
4.6.1 Circadian Rhythm Sleep Disorders Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Arena Pharmaceuticals
5.1.1 Arena Pharmaceuticals Profile
5.1.2 Arena Pharmaceuticals Main Business
5.1.3 Arena Pharmaceuticals Circadian Rhythm Sleep Disorders Products, Services and Solutions
5.1.4 Arena Pharmaceuticals Circadian Rhythm Sleep Disorders Revenue (US$ Million) & (2018-2023)
5.1.5 Arena Pharmaceuticals Recent Developments
5.2 Boehringer Ingelheim
5.2.1 Boehringer Ingelheim Profile
5.2.2 Boehringer Ingelheim Main Business
5.2.3 Boehringer Ingelheim Circadian Rhythm Sleep Disorders Products, Services and Solutions
5.2.4 Boehringer Ingelheim Circadian Rhythm Sleep Disorders Revenue (US$ Million) & (2018-2023)
5.2.5 Boehringer Ingelheim Recent Developments
5.3 Fabre-Kramer Pharmaceuticals
5.3.1 Fabre-Kramer Pharmaceuticals Profile
5.3.2 Fabre-Kramer Pharmaceuticals Main Business
5.3.3 Fabre-Kramer Pharmaceuticals Circadian Rhythm Sleep Disorders Products, Services and Solutions
5.3.4 Fabre-Kramer Pharmaceuticals Circadian Rhythm Sleep Disorders Revenue (US$ Million) & (2018-2023)
5.3.5 Jazz Pharmaceuticals Recent Developments
5.4 Jazz Pharmaceuticals
5.4.1 Jazz Pharmaceuticals Profile
5.4.2 Jazz Pharmaceuticals Main Business
5.4.3 Jazz Pharmaceuticals Circadian Rhythm Sleep Disorders Products, Services and Solutions
5.4.4 Jazz Pharmaceuticals Circadian Rhythm Sleep Disorders Revenue (US$ Million) & (2018-2023)
5.4.5 Jazz Pharmaceuticals Recent Developments
5.5 Merck & Co
5.5.1 Merck & Co Profile
5.5.2 Merck & Co Main Business
5.5.3 Merck & Co Circadian Rhythm Sleep Disorders Products, Services and Solutions
5.5.4 Merck & Co Circadian Rhythm Sleep Disorders Revenue (US$ Million) & (2018-2023)
5.5.5 Merck & Co Recent Developments
5.6 Glaxo Smith Kline
5.6.1 Glaxo Smith Kline Profile
5.6.2 Glaxo Smith Kline Main Business
5.6.3 Glaxo Smith Kline Circadian Rhythm Sleep Disorders Products, Services and Solutions
5.6.4 Glaxo Smith Kline Circadian Rhythm Sleep Disorders Revenue (US$ Million) & (2018-2023)
5.6.5 Glaxo Smith Kline Recent Developments
5.7 Respirerx Pharmaceuticals
5.7.1 Respirerx Pharmaceuticals Profile
5.7.2 Respirerx Pharmaceuticals Main Business
5.7.3 Respirerx Pharmaceuticals Circadian Rhythm Sleep Disorders Products, Services and Solutions
5.7.4 Respirerx Pharmaceuticals Circadian Rhythm Sleep Disorders Revenue (US$ Million) & (2018-2023)
5.7.5 Respirerx Pharmaceuticals Recent Developments
5.8 Neurocrine Biosciences
5.8.1 Neurocrine Biosciences Profile
5.8.2 Neurocrine Biosciences Main Business
5.8.3 Neurocrine Biosciences Circadian Rhythm Sleep Disorders Products, Services and Solutions
5.8.4 Neurocrine Biosciences Circadian Rhythm Sleep Disorders Revenue (US$ Million) & (2018-2023)
5.8.5 Neurocrine Biosciences Recent Developments
6 North America
6.1 North America Circadian Rhythm Sleep Disorders Market Size by Country (2018-2029)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Circadian Rhythm Sleep Disorders Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Circadian Rhythm Sleep Disorders Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Circadian Rhythm Sleep Disorders Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Circadian Rhythm Sleep Disorders Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Circadian Rhythm Sleep Disorders Market Dynamics
11.1 Circadian Rhythm Sleep Disorders Industry Trends
11.2 Circadian Rhythm Sleep Disorders Market Drivers
11.3 Circadian Rhythm Sleep Disorders Market Challenges
11.4 Circadian Rhythm Sleep Disorders Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List